These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 10206542)

  • 1. One-pot synthesis of 2-substituted 4H-3,1-benzoxazin-4-one derivatives under mild conditions using iminium cation from cyanuric chloride/dimethylformamide as a cyclizing agent.
    Shariat M; Samsudin MW; Zakaria Z
    Chem Cent J; 2013 Mar; 7(1):58. PubMed ID: 23537478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.
    Aliter KF; Al-Horani RA
    Med Chem; 2024 Apr; ():. PubMed ID: 38676528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica-bound benzoyl chloride mediated the solid-phase synthesis of 4H-3,1-benzoxazin-4-ones.
    Rad-Moghadam K; Rouhi S
    Beilstein J Org Chem; 2009 Apr; 5():13. PubMed ID: 19478965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-mediated oxythiolation of
    Yang Y; Liu L; Li K; Zha Z; Sun Q; Wang Z
    RSC Adv; 2022 Mar; 12(12):7347-7351. PubMed ID: 35424675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteome screening of the Lyme disease agent identifies inhibitors of antibody-mediated complement killing.
    Pereira MJ; Wager B; Garrigues RJ; Gerlach E; Quinn JD; Dowdell AS; Osburne MS; Zückert WR; Kraiczy P; Garcia BL; Leong JM
    Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2117770119. PubMed ID: 35312359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery.
    Rushing BR; Rohlik DL; Roy S; Skaff DA; Garcia BL
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32899120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand.
    Negri A; Li J; Naini S; Coller BS; Filizola M
    J Comput Aided Mol Des; 2012 Sep; 26(9):1005-15. PubMed ID: 22893377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Amino- and 2-alkylthio-4H-3,1-benzothiazin-4-ones: synthesis, interconversion and enzyme inhibitory activities.
    Häcker HG; Grundmann F; Lohr F; Ottersbach PA; Zhou J; Schnakenburg G; Gütschow M
    Molecules; 2009 Jan; 14(1):378-402. PubMed ID: 19145216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.
    Barnum SR
    Mol Med; 1999 Sep; 5(9):569-82. PubMed ID: 10551898
    [No Abstract]   [Full Text] [Related]  

  • 10. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.
    Plummer JS; Cai C; Hays SJ; Gilmore JL; Emmerling MR; Michael W; Narasimhan LS; Watson MD; Wang K; Nath R; Evans LM; Jaen JC
    Bioorg Med Chem Lett; 1999 Mar; 9(6):815-20. PubMed ID: 10206542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
    Hays SJ; Caprathe BW; Gilmore JL; Amin N; Emmerling MR; Michael W; Nadimpalli R; Nath R; Raser KJ; Stafford D; Watson D; Wang K; Jaen JC
    J Med Chem; 1998 Mar; 41(7):1060-7. PubMed ID: 9544206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of newly synthesized active center-directed trypsin-like serine protease inhibitors on the complement system.
    Ueda N; Midorikawa A; Ino Y; Oda M; Nakamura K; Suzuki S; Kurumi M
    Inflamm Res; 2000 Jan; 49(1):42-6. PubMed ID: 10778920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.